James Elvecrog
Impact in
- Immunology top 10%
- Immunotherapy and Immune Responses
- Immune Response and Inflammation
- Immune Cell Function and Interaction
- Immune cells in cancer
-
- Cancer Immunotherapy and Biomarkers
Papers in
-
- Immune Response and Inflammation 3
- Immunotherapy and Immune Responses 2
- Oncology 3
- Cancer Immunotherapy and Biomarkers 2
- Co-authors
- Mark A. Tomai (4 shared papers)Christopher B. Fox (3 shared papers)Ashenafi Y. Tilahun (2 shared papers)John P. Vasilakos (2 shared papers)Ronald Herbst (1 shared paper)Andrew J. Leishman (1 shared paper)Matthew J. Elder (1 shared paper)Robert W. Wilkinson (1 shared paper)
- Journals
- Journal for ImmunoTherapy of Cancer (2 papers)Vaccine (1 paper)Journal of Controlled Release (1 paper)Journal of Pharmaceutical Sciences (1 paper)npj Vaccines (1 paper)
- Partner nations
- United StatesSouth KoreaFrance
In The Last Decade
James Elvecrog
7 papers receiving 365 citations
Peers
Comparison fields: 5 of 54
- Immunology 249
- Oncology 88
- Infectious Diseases 58
- Microbiology 19
- Virology 14
Countries citing papers authored by James Elvecrog
This map shows the geographic impact of James Elvecrog's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James Elvecrog with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James Elvecrog more than expected).
Fields of papers citing papers by James Elvecrog
This network shows the impact of papers produced by James Elvecrog. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James Elvecrog. The network helps show where James Elvecrog may publish in the future.
Co-authors
The 25 scholars most cited alongside James Elvecrog, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 149 | |
| 2 | 2017 | 74 | |
| 3 | 2016 | 55 | |
| 4 | 2018 | 34 | |
| 5 | 2017 | 23 | |
| 6 | 2017 | 23 | |
| 7 | 2016 | 17 |
About James Elvecrog
James Elvecrog is a scholar working on Immunology, Oncology, Infectious Diseases, Parasitology and Small Animals, having authored 7 papers that have together received 375 indexed citations. Recurring topics across this work include Immune Response and Inflammation (3 papers), Cancer Immunotherapy and Biomarkers (2 papers), Immunotherapy and Immune Responses (2 papers), Amoebic Infections and Treatments (2 papers), Viral gastroenteritis research and epidemiology (1 paper), Diagnosis and treatment of tuberculosis (1 paper), Hepatitis Viruses Studies and Epidemiology (1 paper) and Influenza Virus Research Studies (1 paper). The work is most often cited by research in Immunology (249 citations), Oncology (88 citations), Infectious Diseases (58 citations), Microbiology (19 citations) and Virology (14 citations). James Elvecrog has collaborated with scholars based in United States, South Korea and France. Frequent co-authors include Mark A. Tomai, Christopher B. Fox, Ashenafi Y. Tilahun, John P. Vasilakos, Ronald Herbst, Andrew J. Leishman, Matthew J. Elder, Robert W. Wilkinson, Iwen F. Grigsby and Simon J. Dovedi. Their work appears in journals such as Journal for ImmunoTherapy of Cancer, Vaccine, Journal of Controlled Release, Journal of Pharmaceutical Sciences and npj Vaccines.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.